Darbepoetin alfa for chemotherapy-induced anemia: evolution to extended dosing intervals.

Vansteenkiste, Johan

Darbepoetin alfa for chemotherapy-induced anemia: evolution to extended dosing intervals. [electronic resource] - Expert review of anticancer therapy Oct 2007 - 1347-55 p. digital

Publication Type: Journal Article; Review

1744-8328

10.1586/14737140.7.10.1347 doi


Anemia--chemically induced
Antineoplastic Agents--adverse effects
Blood Transfusion
Clinical Trials as Topic--statistics & numerical data
Combined Modality Therapy
Darbepoetin alfa
Drug Administration Schedule
Drug Approval
Erythropoietin--administration & dosage
Humans
Injections, Intravenous
Injections, Subcutaneous
Iron-Dextran Complex--administration & dosage
Neoplasms--blood
Quality of Life
Randomized Controlled Trials as Topic--statistics & numerical data
Thromboembolism--chemically induced